In 2024, the U.S. Drug Enforcement Administration (DEA) indicated which they plan to reclassify cannabis to be a Schedule III drug. This rescheduling will figure out that cannabis has legitimate medical purposes and will help open up the doorway to study on other possible therapy utilizes. Ri